Abstract:To investigate the sensitivity of a 2D-transit EPID-based in-vivo dosimetry system (IVD) in highlighting the accuracy of target dose coverage for volumetric modulated arc therapy (VMAT) post mastectomy irradiations. CT datasets of an Alderson phantom were imported into a treatment planning system; 6MV photon beam of an Elekta Axesse equipped with aSi detectors EPID was selected for the treatment. The CTV and organs at risks (OARs) were delineated while the PTV was obtained with a 3mm isotropic expansion of the CTV. The VMAT treatment plan (TP) was prepared according to the clinical protocol of our center.18 setup variations were introduced shifting the isocenter in the up, down, left, right, in, out directions, of 3, 5 and10 mm; 18 corresponding VMAT TPs were optimized. Dose volume histogram (DVH) endpoints for the heart (Dmean), for the CTV (D95%, D98%) and for the left lung (V20Gy) were used to identify the configurations for which the considered endpoints were most different from the reference ones (absolute difference D95%, D98%, Dmean > 2Gy, and VxGy> 5%). EPID images acquired for each beam of each plan were analysed with Softdiso that supplies two types of tests: the ratio R between the reconstructed and planned isocenter doses and a transit dosimetry based on the γ-analysis of the electronic portal images, using 5%-5mm signal and distance to agreement gamma criteria. The tests were considered in tolerance, if R was within 5%, γ% >90% and if γ mean ≤ 0.4. Of the 18 perturbed plans, the ones obtained with a 3mm isocenter shifts did not present any DVH difference compared to the reference plan. The IVD analysis of the EPID images acquired for these perturbed plans confirmed these results registering indices within the tolerance level: y% (range 95%-100%), ymean (range 0.33-0.38), R (range 0.99-1). Significant DVH differences (CTV D95 and D98 absolute difference up to 11.95 and 15.79 Gy respectively and lung V20 up to +20%) were obtained for some of the 10 mm isocenter shifts. In these cases, y% (range 82%-90%) and ymean (range 0.50-0.65) resulted out of the tolerance level. The ratio R resulted less sensitive to 3D dose coverage variations and remained unvaried. In the situations presenting slight differences of the DVH endpoints, the indices registered remained near the acceptable threshold. In the Table below some representative results of the different scenarios are shown. The gamma analysis of the acquired EPID images provided by Softdiso is able to highlight discrepancies on target dose coverage for VMAT postmastectomy irradiation.Abstract 3723; Table 1Perturbed vs Reference Absolute differencePerturbationIVD indicesCTV D95%(DGy)CTV D98%(DGy)Lung, V20Gy (D%)Heart, Dmean (DGy)Isocenter Shift (cm)g % (5%;5mm) – gmeanR-12.0-15.8+20-2.8Up (1)84%-0.571.01-9.1-12.9-6+0.3Right (1)82%-0,651.00-4.2-6.9-5-0.5In (1)90%-0.501.00-2.2-3.8-3+0.2Right (0.5)90%-0.450.990.20.3+2+0.2Out (0.3)99%-0.340.99-0.60.7-1-0.2In (0.3)98%-0.371.00 Open table in a new tab

Preliminary Results on In-Vivo Dose Measurement of Intensity-Modulated Radiotherapy for Cervical Cancer

Comparison of Computed Tomography- and Magnetic Resonance Imaging-Based Target Delineation for Cervical Cancer Brachytherapy

Preliminary study of in vivo dose measurement of intensity-modulated radiotherapy for cervical cancer

Effectiveness of a 2D-Transit Epid-Based In-Vivo Dosimetry System in Highlighting the Accuracy of Target Dose Coverage for Post-Mastectomy VMAT Irradiation

EPID for Set-up Errors Analysis and Quality Assurance of Radiotherapy in Head and Neck Cancer

Evaluation of Interfraction Setup Variations for Postmastectomy Radiation Therapy Using EPID‐based in Vivo Dosimetry

A clinical test and application research of IMRT dose verification system based on patient' s anatomical structure and on-line dosimetry

Comparison of 3D Anatomical Dose Verification and 2D Phantom Dose Verification of IMRT/VMAT Treatments for Nasopharyngeal Carcinoma.

Setup error analysis for cervical cancer in image guided intensitymodulated radiotherapy

The Impact of Electronic Portal Imaging Device Position Error on 3D Dose Verification of Volumetric Modulated Arc Therapy

A method for in vivo treatment verification of IMRT and VMAT based on electronic portal imaging device

Measurement and analysis of setup error in intensity modulated radiation therapy for head-neck tumor

In Vivo Dose Monitoring Using an Electronic Portal Imaging Device As a Tool to Reduce the Risk of Protracted Radiation Misadministration

Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer

A Preliminary Simulation Study of Dose-Guided Adaptive Radiotherapy Based on Halcyon MV Cone-Beam CT Images With Retrospective Data From a Phase II Clinical Trial

Efficacy Of Epid-Based In Vivo Dosimetry And Calibrated Cbct Images For A Timely Lung Cancer Replanning

The preliminary comparison of the reconstructed doses with electronic portal imaging device (EPID) and dynalogs files for in vivo phantom dosimetry

The study of clinical target volume motion of radical intensity-modulated radiotherapy for non-surgical cer-vical cancer patients by cone beam computed tomography

Dosimetric Research into Target Regions and Organs at Risk in Three-Dimensional Intracavitary Brachytherapy Techniques for Chinese Patients with Cervical Carcinoma

A Clinically Relevant Online Patient QA Solution with Daily CT Scans and EPID-basedin Vivodosimetry: a Feasibility Study on Rectal Cancer.

Preliminary Clinical Outcomes and Dosimetry Study on Adaptive Imrt Integrated Hdr Brachytherapy in Local Advanced Uterine Cervical Cancer.